Results for "HDA Factbook"
Strengthening the Strategic National Stockpile for the Future
The Strategic National Stockpile (SNS) plays a critical role in supplementing state and local supplies during public health emergencies. The lifesaving medicines and healthcare products secured by the stockpile serve as a buffer when supplies may otherwise not be immediately available.
HDA at the Bold Bets Healthcare Summit: Strengthening the Supply Chain for the Future
On June 4, healthcare leaders gathered at the Widehall Bold Bets Healthcare Summit to discuss the opportunities and challenges shaping the industry's future. Sponsored by the HDA, Eli Lilly and BD, the event brought together voices from across government, science and industry to explore topics ranging from artificial intelligence and healthcare affordability to emergency preparedness, innovation and the future of patient care.
Less Than a Year From the DSCSA Deadline, Experts Discuss the Road to Compliance
The Drug Supply Chain Security Act (DSCSA) has entered its final year of implementation. For the past nine years, HDA has brought together supply chain partners, represented distributors’ insights and expertise with FDA and other regulators, and led educational initiatives aimed at informing and preparing supply chain stakeholders for 2023. At the October Traceability Seminar in Washington, D.C., HDA spoke with several industry experts, who were asked to share insights from across the DSCSA’s legislative and implementation process as part of our Faces of the Supply Chain series. Key highlights from these conversations are captured in this piece.